Acadia Healthcare (ACHC) Research Coverage Started at Wells Fargo & Co

Wells Fargo & Co began coverage on shares of Acadia Healthcare (NASDAQ:ACHC) in a report issued on Tuesday, January 30th, MarketBeat reports. The brokerage issued an outperform rating and a $41.00 price objective on the stock.

Several other equities research analysts have also recently weighed in on the company. Zacks Investment Research cut Acadia Healthcare from a hold rating to a sell rating in a research note on Monday, October 2nd. Jefferies Group set a $42.00 price objective on Acadia Healthcare and gave the stock a buy rating in a research note on Wednesday, October 25th. Robert W. Baird cut Acadia Healthcare from an outperform rating to a neutral rating and reduced their price objective for the stock from $55.00 to $38.00 in a research note on Wednesday, October 25th. BMO Capital Markets started coverage on Acadia Healthcare in a research report on Monday, October 16th. They set an outperform rating and a $52.00 target price for the company. Finally, Mizuho restated a neutral rating on shares of Acadia Healthcare in a research report on Monday, October 30th. Eight investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of Buy and an average target price of $43.92.

Shares of Acadia Healthcare (ACHC) opened at $35.66 on Tuesday. Acadia Healthcare has a twelve month low of $26.92 and a twelve month high of $54.34. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36. The stock has a market capitalization of $3,130.00, a PE ratio of 18.19, a PEG ratio of 1.14 and a beta of 0.85.

In other Acadia Healthcare news, Director Reeve B. Waud sold 100,000 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $31.80, for a total value of $3,180,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Acadia Healthcare by 8.9% during the 2nd quarter. Vanguard Group Inc. now owns 6,254,532 shares of the company’s stock worth $308,849,000 after acquiring an additional 511,299 shares in the last quarter. Aristotle Capital Management LLC boosted its stake in shares of Acadia Healthcare by 5.0% during the 4th quarter. Aristotle Capital Management LLC now owns 6,183,866 shares of the company’s stock worth $201,780,000 after acquiring an additional 297,069 shares in the last quarter. Frontier Capital Management Co. LLC boosted its stake in shares of Acadia Healthcare by 13.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 2,903,403 shares of the company’s stock worth $94,738,000 after acquiring an additional 337,961 shares in the last quarter. FMR LLC lifted its stake in Acadia Healthcare by 26.4% in the 2nd quarter. FMR LLC now owns 2,775,451 shares of the company’s stock valued at $137,052,000 after buying an additional 580,449 shares in the last quarter. Finally, State Street Corp lifted its stake in Acadia Healthcare by 95.2% in the 2nd quarter. State Street Corp now owns 1,998,030 shares of the company’s stock valued at $98,667,000 after buying an additional 974,524 shares in the last quarter.

WARNING: “Acadia Healthcare (ACHC) Research Coverage Started at Wells Fargo & Co” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/02/15/acadia-healthcare-achc-coverage-initiated-by-analysts-at-wells-fargo-co.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply